Liraglutide don lura da kiba: sake duba masu ciwon sukari

* Ta danna maɓallin "Submitaddamar", Na ba da izinin aiwatar da bayanan sirri na tare da ka'idar tsare sirri.

Liraglutide, wanda ya sami rarrabuwar kai a Amurka a ƙarƙashin sunan Victoza, ba shi da sabon magani - an yi amfani dashi tun 2009 don maganin cututtukan type 2. Wannan wakili na hypoglycemic an allurar kuma an yarda dashi don amfani a Amurka, Rasha da wasu ƙasashe a cikin nau'in Viktoza daga masana'antar Danish Novo Nordisk. Tun daga shekara ta 2015, ana iya samun Liraglutide ƙarƙashin sunan kasuwanci Saksenda kuma an sanya shi azaman magani don maganin kiba a cikin manya.

A saukake, ana amfani da abu guda mai aiki a ƙarƙashin sunaye na kasuwanci daban-daban don ingantaccen magani na ciwon sukari da kuma kawar da nauyin jiki mai yawa.

Yaya aiki?

Liraglutide kwafin roba ne na mutum mai yin amfani da glucagon-kamar peptide-1 (GLP-1), wanda yake kashi 97% ne da kamannin sa. Sakamakon haka, jikin ba ya bambanta tsakanin ainihin enzymes da aka gina ta hanyar jikin mutum kuma ya gabatar da wucin gadi. Liraglutide a cikin ma'anar glucagon-kamar peptide-1 yana ɗaure wa masu karɓa da ake so kuma yana ƙarfafa samar da insulin, glucagon. A lokaci mai zuwa, ana yin kirkirar hanyoyin halitta na samarda insulin, wanda ke haifar da cutar Normoglycemia.

Sau ɗaya a cikin jini ta hanyar allura, ƙwayar tana ƙara yawan peptides a cikin jiki. Sakamakon haka, an sake dawo da aikin ƙwayar ƙwayar cuta, an rage matakin sukari na jini na mai haƙuri zuwa iyakoki na al'ada. Wannan, bi da bi, yana ba da gudummawa ga cikakken ɗaukakakken abubuwa masu amfani daga abinci, wanda ya ba ku damar kawar da bayyanar cututtuka daban-daban.

Yaya ake amfani da shi don magance kiba

Don kawar da nauyin jiki mai yawa, ya zama dole don amfani da Liraglutid don asarar nauyi, a cikin sashi na sashi "Saksenda". Ana siyar dashi da sifar alkalami, wanda ya sauƙaƙa gabatarwar sa. Akwai rarrabuwa a kan sirinji don ƙayyade adadin da ake buƙata na miyagun ƙwayoyi. Cakuda siffofin sashi shine daga 0.6 zuwa 3 MG a cikin ƙaruwa na 0.6 MG.

Umarnin don amfani da tsari na Saxenda

Girman shawarar da aka bayar na yau da kullun na Saxenda shine 3 MG. A wannan yanayin, babu wani dogaro a kan lokaci, abincin abinci da sauran magunguna. A cikin mako na farko, sashi shine 0.6 MG, kowane mako mai zuwa adadin abu mai aiki yana ƙaruwa da 0.6 MG. Farawa daga mako na 5, kuma har zuwa ƙarshen hanya, mara lafiya yana ɗaukar fiye da 3 MG kowace rana.

Ana gudanar da maganin sau ɗaya a rana a cinya, kafada ko ciki. Ana iya canza lokacin gudanarwa, wanda bai kamata ya shafar yadda ake amfani da maganin ba.

Liauki Liraglutide don asarar nauyi ana bada shawara ne kawai kamar yadda likita yayi. A matsayinka na mai mulkin, an tsara wannan magani ga marasa lafiya da masu ciwon sukari na 2 waɗanda ba sa iya daidaita nauyin su da kansu kuma suna kawar da karin fam. Hakanan, ana amfani da maganin don dawo da ƙididdigar glycemic a cikin waɗannan marasa lafiya waɗanda a ciki wanda wannan alamar ke da rauni.

Umarnin don amfani da miyagun ƙwayoyi

Liraglutide don lura da nau'in ciwon sukari na 2 na ƙwayar cuta da ƙiba dole ne a yi amfani dasu a cikin sashi na Saksenda, za ku iya siyan sa ta azaman sirinji. An shirya rarrabuwa a kan sirinji, suna taimakawa wajen tantance ainihin yawan magungunan da sauƙaƙe gudanarwar ta. Thearfafa yawan abu mai aiki shine daga 0.6 zuwa 3 MG, mataki shine 0.6 MG.

Rana don manya tare da kiba da ciwon sukari na buƙatar 3 MG na miyagun ƙwayoyi, yayin da lokacin rana, ɗaukar abinci da sauran magunguna ba sa taka rawa ta musamman. A cikin makon farko na jiyya, kowace rana wajibi ne don allurar 0.6 mg, kowane mako mai zuwa amfani da sashi yana ƙaruwa da 0.6 MG. Tuni a cikin mako na biyar na magani kuma kafin ƙarshen hanya, ana bada shawara don yin allurar fiye da 3 MG kowace rana.

Ya kamata a gudanar da magunguna sau ɗaya a rana, saboda wannan kafada, ciki ko cinya ya dace sosai. Mai haƙuri na iya canza lokacin gudanar da magani, amma wannan bai kamata a nuna a cikin kashi ba. Don asarar nauyi, ana amfani da miyagun ƙwayoyi don dalilai na endocrinologist.

Yawanci, miyagun ƙwayoyi Viktoza ya zama dole ga masu ciwon sukari irin na 2 waɗanda ba za su iya yin nauyi ba kuma suna daidaita yanayin su akan asalin:

maganin rage cin abinci
shan kwayoyi don rage sukari.

Hakanan yana da mahimmanci a yi amfani da magani don maido da ƙwayar cuta a cikin marasa lafiyar da ke fama da canje-canje a matakan glucose.

Contraindications

rashin haƙuri akan abubuwan da aka gyara,
nau'in ciwon sukari guda 1
mummunan koda da cututtukan hanta,
bugun zuciya na nau'ikan 3 da 4,
mai kumburi hanji cuta,
ciwan kumburin jini,
mahara endocrine neoplasia syndrome,
ciki da lactation.

Ba da shawarar liyafar:

a lokaci guda kamar yadda insulin allurar ciki
tare da kowane agonist mai karɓar GLP-1,
Mutane sama da 75 da haihuwa
marasa lafiya bincikar lafiya tare da pancreatitis (ba karatu jiki dauki).

Tare da taka tsantsan, an wajabta magunguna ga mutanen da ke da alamun cututtukan zuciya. Hakanan ba a bayyana yadda miyagun ƙwayoyi ke nuna halayen yayin ɗaukar su da sauran samfuran asarar nauyi ba. A wannan yanayin, bai cancanci yin gwaji da gwada hanyoyin dabarun magani daban-daban na asarar nauyi ba. Ba a son yara da matasa masu shekaru 18 suyi amfani da wannan magani - shawarar da ke tattare da wannan magani an ƙaddara ta mai halartar likitan mata bayan gwaji da bincike.

Side effects

Mafi kyawun bayyanar atypical wannan ƙwayar cuta cin zarafin ƙwayar gastrointestinal. A cikin 40% na lokuta, tashin zuciya ya bayyana. Daga cikin waɗannan, kusan rabi kuma suna amai. Kowane haƙuri na biyar, ɗaukar wannan magani, yana gunaguni na zawo, da sauran ɓangaren - na maƙarƙashiya. Kimanin 7-8% na mutanen da ke shan magani don asarar nauyi suna korafin ƙara yawan gajiya da gajiya. Musamman taka tsantsan ya kamata su kasance masu haƙuri da nau'in ciwon sukari na 2 na 2 - kowane mara lafiya na uku bayan an tsawaita aikin kula da liraglutide, ana gano hypoglycemia.

Wadannan halayen da basu dace da jiki wadanda suka shafi ɗayan nau'in liraglutide suma suna iya yiwuwa:

ciwon kai
Cutar huhu ta sama
rashin tsoro
karuwa a zuciya,
alerji

Dukkanin sakamako masu illa suna da halayyar makonni na farko ko na biyu na shan miyagun ƙwayoyi dangane da liraglutide. Bayan haka, mitar da tsananin irin wannan yanayin kwayar halitta ta ragu da sannu a hankali ta shuɗe. Tunda liraglutide yana haifar da matsala a cikin ɓoye ciki, wannan yana shafar matakin ɗaukar sauran kwayoyi. Koyaya, canje-canje ƙanƙane, sabili da haka, gyaran kashi na magunguna da aka dauka ba a buƙatar Kuna iya amfani da wannan magani lokaci guda tare da wakilai waɗanda ke ɗauke da metformin ko a cikin hadaddun jiyya tare da metformin da thiazolidinedione.

Tasiri don Rage nauyi

Magunguna sun dogara da sinadaran aiki na liraglutide, suna taimakawa asarar nauyi da farko saboda suna iya rage ƙimar abinci daga ciki. A sakamakon haka, abincin mutum yana raguwa, kuma yana ci kusan kashi 15% cikin ƙasa da wanda yake a da.

Nessarfin maganin zai zama mafi girma idan kun yi amfani da shi azaman ƙari don rage yawan kalori mai ƙima. Ba za a iya amfani da wannan kayan aikin azaman hanyar kawai don rasa nauyi ba. Ba shi yiwuwa a rabu da “balast” tare da taimakon injections kadai. Hakanan ana bada shawara don barin kyawawan halaye da haɓaka ayyukan jiki. A karkashin waɗannan yanayin, sakamakon rasa nauyi bayan kammala karatun shine 5% a cikin rabin waɗanda ke shan miyagun ƙwayoyi da kuma 10% a kwata na marasa lafiya da ciwon sukari. Gabaɗaya, fiye da 80% na marasa lafiya suna ba da rahoton halayen kirki na rasa nauyi bayan sun fara amfani da wannan magani. Ana iya tsammanin irin wannan sakamakon kawai idan sashi don yawancin maganin bai zama ƙasa da 3 MG ba.

Kudin samar da liraglutide an ƙaddara shi da sashi na abu mai aiki.

Maganin "Victoza" don gudanarwar subcutaneous na 6 MG / ml, 3 ml, N2 (Novo Nordisk, Denmark) - daga 10,000 rubles.
Kayan katako "Victoza" tare da alkalami na syringe 6 mg / ml, 3 ml, inji 2. (Novo Nordisk, Denmark) - daga 9.5 dubu rubles.
Victoza, 18 mg / 3 ml-syringe, 2 inji mai kwakwalwa. (Novo Nordisk, Denmark) - daga 9 dubu rubles.
Maganar "Saksenda" don gudanar da aikin subcutaneous na 6 MG / ml, kabad a cikin sirinji alkalami 3 ml, 5 inji mai kwakwalwa. (Novo Nordisk, Denmark) - 27,000 rubles.

Liraglutide a cikin nau'in "Victoza" da "Saxenda" suna da alamun analogues da yawa waɗanda ke da tasiri iri ɗaya a jiki da warkewa:

Ana amfani da Novonorm (Allunan, daga 140 zuwa 250 rubles) don bi da mellitus na sukari na 2, sannu a hankali yana rage sukarin jini.
“Baeta” (alkalami mai sirinji, kusan dubu 10 rubles) - yana nufin amino acid amidopeptides. Yana hana narkewar ciki, yana rage ci.
"Lixumia" (alkalami mai sirinji, daga 2.5-7 dubu rubles) - rage yawan haɗuwar glucose a cikin jini, ba tare da la'akari da yawan abinci ba.
"Forsiga" (Allunan, daga 1.8-2,8 dubu rubles) - yana hana shan glucose, rage yawan hankali bayan cin abinci.

Yadda yake barata shine amfani da analogues maimakon Liraglutide don asarar nauyi, likitan halartar ya yanke hukunci. Yanke kai tsaye cikin wannan lamarin bai dace ba, tunda zasu iya haifar da ci gaban halayen mutane da yawa da kuma rage tasirin warkewa.

Nazarin da sakamakon rasa nauyi

Valentina, 49 years old

Bayan wata daya na shan liraglutide, an kiyaye sukari a 5.9 mmol / L, kodayake kusan bai faɗi ƙasa 10 ba har ma ya kai 12. Tabbas, na haɗu da maganin tare da rage cin abinci, na watsar da yawancin abincin da nake so amma cutarwa. Amma na manta game da zafin da ke cikin farji da kuma rashin nauyi, tunda an riga an rasa kilo 3!

Bayan haihuwar ɗana na biyu, lafiyata ta girgiza sosai. Na dawo da 20 kilogiram, kuma ban da haka na sami nau'in ciwon sukari na 2. Likitan ya shawarci maganin Saksenda. Shi, ba shakka, ba shi da arha, amma yana kashe kuɗi. Na farko, bayan allura, kai na yana zube, kuma tana fama da rashin lafiya, yanzu ga shi ana amfani da gawar. Don watanni 1.5 na shigowa, Na rasa kilo 5, kuma lafiyar ta ta inganta sosai. Yanzu kula da yara bashi da wahala.

Nazarin likitoci da kwararru

Leonova Tatyana, Yaroslavl. Masana ilimin dabbobi

Ina wajabta maganin Liraglutide akai-akai, tunda babban burin da ake samu a cikin lura da ciwon sukari shine a sami tsayayyen raguwar sukari cikin jini tare da ƙarancin sakamako ga jikin mutum. Wannan burin shine wanda za'a iya cimma nasara tare da kwayoyi masu kama da wannan, amma mafi araha. Gabaɗaya, Na lura cewa Liraglutid ya jimre tare da ayyuka, amma ya ba da cewa mai haƙuri ya cika duk shawarar - yana daidaita abincin, yana cikin aiki na jiki. A wannan yanayin, ban da rage sukari, ana lura da asarar nauyi na kilogiram 5-7 na tsawon watanni biyu.

Dudaev Ruslan, Mai tsoro. Masana ilimin dabbobi

Idan mai haƙuri yana da damar biyan magani tare da Lyraglutide, Ina ba da shawarar wannan magani a gare shi. Ya tabbatar da ingancinsa ba kawai a lura da ciwon sukari na 2 ba, har ma da kawar da nauyin mai yawa. Koyaya, Na nace akan ingantaccen hukuncin umarnin don rage yiwuwar tasirin sakamako. Bugu da ƙari, tare da asara mai nauyi, ana bada shawarar yin amfani da miyagun ƙwayoyi don tsayayyen sakamako mai ƙoshin lafiya.

Yadda ake yakar kiba

Akwai maganganu da yawa game da kiba, taron karawa juna sani da majalisai ana gudanarwa a matakan kasa da kasa game da cutar sankara, cututtukan fata, magani gabaɗaya, an gabatar da hujjoji da nazari game da sakamakon wannan cutar, kuma kawai hakan ne ga kowane mutum, yawan kiba ya zama koyaushe matsala ce. Don taimaka wa marasa lafiya ku rage nauyin jiki kuma don kiyaye sakamakon da aka samu, yana da matukar muhimmanci a nemi shawarar ƙwararrun masani a fannin kimiyyar ilimin halittar jiki da kuma tsarin abinci.

Kiyaye duk abubuwan da aka ambata a sama, da farko, ya wajaba a yanke tarihin cutar sosai. Abu mafi mahimmanci don kula da kiba shine saita babban manufa - wanda ke buƙatar asarar nauyi. Kawai sai a iya wajabta maganin sosai. Wato, tunda an ayyana ƙayyadaddun manufofi a cikin sha'awar rage nauyin jiki, likita ya tsara shirin don lura da masu haƙuri a nan gaba.

Magungunan kiba

Ofaya daga cikin magungunan don magance wannan cuta ta hormonal ita ce magani Liraglutide (Liraglutide). Ba sabon abu bane, an fara amfani dashi ne a shekarar 2009. Kayan aiki kayan aiki ne wanda ke rage abun cikin sukari a cikin jini kuma ana shigar dashi a jiki.

Ainihin, an wajabta shi don kamuwa da cutar sukari na 2 ko a cikin magance kiba, a zahiri don hana shan abinci (glucose) a cikin ciki. A halin yanzu, an ƙaddamar da samar da miyagun ƙwayoyi da ke da sunan kasuwanci daban-daban "Saxenda" (Saxenda) a kasuwannin cikin gida sanannu ne ga alamar kasuwanci mai ɗabi'a "Viktoza". Ana amfani da abu guda ɗaya tare da sunaye daban-daban na kasuwanci don kula da marasa lafiya da tarihin ciwon sukari.

Liraglutide an yi shi ne don maganin kiba. Kiba shine, mutum zai iya cewa, “kaddarawar” aukuwar cutar sankarau a kowane zamani. Don haka, yaƙar kiba, muna hana farawa da haɓakar ciwon sukari.

Ka'idojin aiki

Magungunan shine wani abu da aka samu na roba, mai kama da peptide-glucagon kamar mutum. Magungunan yana da tasiri na dogon lokaci, kuma kwatankwacin shine 97% tare da wannan peptide. Wato, lokacin da aka gabatar da shi a cikin jiki, yana ƙoƙari ya yaudare shi. Sakamakon haka, jikin ba ya ga bambanci tsakanin waɗannan enzymes ɗin daga magungunan da aka gabatar da su. Yana daidaitawa akan masu karɓar. A wannan yanayin, ana samar da insulin sosai. A cikin wannan rawar, GLP glucone peptide antagonist shine wannan magani.
A tsawon lokaci, akwai rage ƙarancin hanyoyin da suke da alhakin samar da insulin. Wannan yana haifar da daidaituwa ga matakan sukari na jini.
Penetrating cikin jini, liraglutide yana samar da karuwa a yawan jikin peptide. A sakamakon wannan, cututtukan farji da aikinta ya dawo daidai. A zahiri, sukarin jini ya sauka zuwa matakan al'ada. Abincin da ke shiga jiki tare da abinci yana fara zama mafi kyau, matakan sukari na jini ana daidaita su.

Gyara daidaitawa

Fara da 0.6 MG. Sannan yana ƙaruwa da wannan adadin mako-mako. Kawo zuwa 3 MG ka bar wannan sashi har sai hanya ta cika. Ana gudanar da miyagun ƙwayoyi ba tare da iyakance tazara ta yau da kullun ba, abincin rana ko amfani da wasu magunguna a cinya, kafada ko ciki. Za'a iya canza wurin allurar, amma sashi ba ya canzawa.

Wanda aka nuna don maganin

Jiyya tare da wannan magani ana ba da izinin likita kawai (!) Idan babu daidaitaccen tsari na nauyi a cikin masu ciwon sukari, to an tsara wannan maganin. Aiwatar da shi kuma idan hypoglycemic index ya keta.

Contraindications don amfani:

Akwai yiwuwar shari'o'in rashin haƙuri na mutum mai yiwuwa ne.
Kada kuyi amfani da su don ciwon sukari na 1
Mai tsananin cutar koda da kuma hepatic Pathology.
Nau'in 3 da 4 na rashin zuciya.
Pathology na ciki wanda ya shafi kumburi.
Kalmar haila ta.
Ciki

Idan akwai injections na insulin, to a lokaci guda ba a bada shawarar magani ba. Ba a so a yi amfani da shi a ƙuruciya da waɗanda suka ƙetare bakin shekaru na 75. Tare da matsanancin taka tsantsan, ya zama dole don amfani da miyagun ƙwayoyi don cututtukan zuciya daban-daban.

Sakamakon amfani da miyagun ƙwayoyi

Ayyukan miyagun ƙwayoyi ya dogara ne akan gaskiyar cewa shan abinci daga ciki yana hana.Wannan yana haifar da rage yawan ci, wanda ya haifar da rage yawan abincin da kimanin 20%.
Hakanan a cikin maganin kiba ana amfani da shirye-shiryen Xenical (abu mai aiki orlistat), Reduxin, daga sababbin kwayoyi na Goldline Plus (abu mai aiki shine sibutramine dangane da miyagun ƙwayoyi), kazalika da aikin tiyata.

Muna kuma ba da shawara cewa ku san kanku da sababbin hanyoyin samar da magani a cikin ilimin zamani yadda za ku sami ingantaccen nauyi:

Kiba mafi munin makiyi ne ga al'umma ta zamani, fara gwagwarmaya wanda, da farko, bai kamata ku manta game da yunƙurin yaƙar wannan cuta ta hormonal ba, tuntuɓar mai kula da lafiyarku da kuma maganin endocrinologist wanda zai tsara da kuma daidaita shirin jinya na gaba. Abun kula da kai tare da waɗannan magunguna an haramta shi sosai, wanda kawai za'a iya amfani dashi kamar yadda likitanka ya umarta.

Game da magani

Liraglutide don asarar nauyi shine ingantaccen ingantaccen kayan aiki wanda ya bayyana akan kasuwar Rasha a 2009. An ba da izinin amfani dashi ba kawai a cikin Rasha ba, har ma a Amurka da wasu jihohi. Wanda ya kirkiro da kayan kamfanin Novo Nordisk an yi rajista a Denmark.

Ana samun magungunan a cikin hanyar allurar subcutaneous. Babban burinta shine tasiri cikin farji. Hakanan kwayoyi suna kara tsoratar da wasu nau'ikan kwayoyin halittun da ke da alhakin saitin:

glucagon,
insulin
nauyin jiki.

Shin kun san cewa a cikin Amurka, Saxenda shine magani na 4 wanda aka amince dashi don amfani dashi azaman don rage wuce kima?

Yi la'akari da kowane ɗayan magunguna guda 2 cikin ƙarin bayanai:

Akwai Victose a cikin sirinji da aka cika da 3 ml na bayani. Matsakaicin kasuwar sa shine 158 USD. Ya kasance tare da Victoza, a cikin 2009, an fara amfani da Liraglutide a magani. Wannan kayan aikin ya inganta. A sakamakon haka, miyagun ƙwayoyi Saksenda ya bayyana.
Saxenda alkalami 5 ne mai dauke da maganin. Kowane alkalami ya ƙunshi 3 MG na bayani. An ba da kayan aiki mai sikelin tare da rarrabuwa kuma an yi niyya don da yawa injections. Adadin ya dogara da sashi. Farashin samfurin magani daga 340.00 zuwa 530.00 USD. Baya ga Liraglutida, sun haɗa da:

Propylene Glycol,
Nátrii Hydroxídum,
Phenol
Phosphate hydrogen foda na bushewa
Liquid don allura.

Saxenda, azaman shirye-shiryen da aka sabunta na zamani, yana da fa'idodi da yawa akan Viktoza. Wannan shi ne:

rage sakamako masu illa
mafi inganci yaki da kiba,
mafi dace don amfani.

Victoza an samo asali ne don warkar da ciwon sukari, saboda masana ilimin abinci sau da yawa sun fi son takwararta.

Clinical sakamako, kaddarorin, contraindications

Ragewa cikin ƙwayar adipose kuma, a sakamakon haka, asarar nauyi, ta faru sakamakon ƙaddamar da kayan aikin 2:

yunwa ta shuɗe
rage yawan kuzari.

Amfani da ƙwaƙwalwar asarar nauyi Lyraglutid yana ba da sakamako kamar haka:

Matakan sukari sun koma daidai
saboda karuwa a matakin peptides, aikin farji yana daidaita shi,
matsanancin abinci yana da sauri, yayin da jiki yake ɗaukar daga samfuran abinci da ke cikinsu,
kwakwalwa nan da nan aka basu siginar cewa saturation ya cika,
yawan cin abinci na faruwa.

Magungunan hana amfani da kwayoyi masu ɗauke da ƙwayoyin cutar liraglutide sune:

cututtukan thyroid
bugun zuciya
rikice-rikice da tafiyar matakai mai kumburi a cikin narkewa,
sabawa daga tunanin mutum tunani,
koda mai aiki,
cutar hanta
maganin ciwon huhu
endocrine neoplasia,
lactation
ciki
rashin haƙuri zuwa ga sinadaran da miyagun ƙwayoyi,
ciwon sukari I

Waɗannan dalilai ne na kai tsaye don ƙin shan maganin. Likitocin sun kuma ambata wasu dalilai na kai tsaye:

cututtuka na tsarin zuciya da jijiyoyin jini,
shan magunguna masu ɗauke da GLP-1 (insulin, da sauransu),
shan wasu hanyoyin inganta asarar nauyi,
shekaru kasa da shekara 18 kuma sama da 75.

A cikin waɗannan halayen, zaku iya ɗaukar Saxenda ko Victoza kawai kamar yadda likita ya umarta kuma a ƙarƙashin kulawarsa mai kulawa. A farkon zargin yiwuwar sakamako masu illa, an soke maganin.

Wadanda ke shan miyagun ƙwayoyi suna lura da sakamako masu illa da yawa:

ci abinci, wanda za'a iya ɗaukarsa azaman nagarta,
daga numfashi
daban-daban nau'in kasawa a cikin gastrointestinal fili:
maƙarƙashiya
zawo
burps mai ban sha'awa
kamar haka, gastroesophageal reflux,
zafi
dyspepsia
rashin tsoro
bloating
amai
tashin zuciya
ciwon kai
bushewa
hawan jini,
bacin rai
aiki da sauri
bari
sauke cikin aiki
halayen rashin lafiyan halayen
farhythmia,
anorexia.

Wadannan sakamako masu illa suna sa ka tuna da faɗin “Mma tana bukatar sadaukarwa”. Jawabin ba na tilas bane amma zai yuwu. Bayan shan miyagun ƙwayoyi, komai zai koma al'ada.

Umarnin don amfani da sakamako

Maƙerin sun haɗu da umarnin don amfani da Liraglutide:

Dole ne a gudanar da miyagun ƙwayoyi:

kawai subcutaneously
sau ɗaya a kowace awa 24
a lokaci guda (na tilas ne)
allura a cinya, ciki, ko kafada.

Shawarar farko da aka bada shawarar 1.8 MG, akan lokaci, za'a iya kawo shi zuwa 3 MG.
Ba a yarda da sigar biyu ba lokacin rana.
Lokacin karbar kudin daga watanni 4 ne zuwa shekara (wanda likita ya tsara).
Idan dalilin ɗaukar nauyi shine asarar nauyi, kuna buƙatar shiga don wasanni kuma ku ci abinci.
Tare tare da liraglutide, thiazolidinediones da metformin ana tsara su sau da yawa.
Ana adana maganin a cikin firiji a wani matsakaicin zafin jiki na + 2 ° C (kar a bar daskarewa).
Ana amfani da miyagun ƙwayoyi na wata daya.

Ana yin maganin sashi ne ta masana'anta, amma likita na iya yin gyare-gyare a ciki.

Nazarin masana kwararru

Za su taimaka wajen yanke shawara, shan magunguna ko kuma neman wani magani, sake dubawa game da Liraglutid don asarar nauyi, likitoci suka rubuta. Mun bayar da wasu daga cikinsu:

Pimenova G.P., endocrinologist, Rostov-on-Don, shekaru 12 gwaninta:

“Liraglutide na daya daga cikin magungunan da nake ba wa marassa lafiya damar rage sukarin jini. Ba tare da ɓata lokaci ba saboda tsadar magungunan. A layi daya tare da babban aikin, ana kuma rage raguwa a cikin jigon taro na jiki. Inganci da saurin asarar nauyi yana dogara ne kai tsaye da yarda da masu haƙuri tare da shawarwari na, wanda na keɓance daban-daban. Sakamakon kuma ya dogara da abincin da ake amfani da shi. ”

Orlov E.V., likitancin abinci, Moscow, ƙwarewar shekaru 10:

"Ina rubuto magunguna bisa ga Lyraglutide a hankali. A gefe guda, ba kowa bane ke da ikon biyan wannan nau'in kuɗi; a gefe guda, wannan magani shine aka tsara don marasa lafiya da ciwon sukari. Shan magani ba tare da ka'ida ba zai yuwu ne kawai karkashin kulawa ta fuskar lafiya. "

Stepanova L. R., endocrinologist, MD, Murmansk, shekaru 17 na gwaninta:

“A asibitinmu, Liraglutide shine babbar hanyar da ake bi don magance cutar sukari da kiba, wanda ke haifar da cututtuka da yawa. Abin takaici, marasa lafiya masu arziki ne kawai zasu iya biyan maganin. Farashinsa ya cika sosai, kuma hanyar karɓar kudin na iya kasancewa har zuwa shekara guda. Sakamakon yana ɓataccen ɓata. Ko da yake, yana daya daga cikin hanyoyin ingantacciyar hanyar yakar masu kiba da masu ciwon sukari. "

Binciken likitoci da masana abinci masu gina jiki suna ta da hankalin mutane waɗanda suke son rasa nauyi don siyan magunguna tare da liraglutide.